Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 385

Synctera draws funding in Diagram-backed round

Power Corporation-allied Diagram Ventures helped Synctera pick up $12.4m in a round announced as the financial technology marketplace publicly launched.

Dec 9, 2020

Gupta unveils PruVen fund

Prior to founding venture firm PruVen in the summer, Ramneek Gupta had co-founded the venture investing efforts at financial services firm Citi. 

Dec 9, 2020

DoorDash lets in $3.37bn through IPO

SoftBank Vision Fund is the largest investor in the food delivery service, which has priced an upsized initial public offering roughly doubling its valuation six months ago.

Dec 9, 2020

Silverback swells IPO to near $278m

The underwriters have taken up the over-allotment option in BMS and Celgene-backed oncology drug developer Silverback's initial public offering.

Dec 9, 2020

Corporates help Dragos drag in $110m

National Grid Partners and Koch Disruptive Technologies co-led the industrial cybersecurity product developer's series C round, taking its total funding to $158m.

Dec 9, 2020

RayzeBio lays out $105m in series B

Alexandria Venture Investments was among the participants in the cancer radiotherapy startup's second round in under two months.

Dec 9, 2020

Deepcell caps $20m series A

Stanford University supplied capital to help its AI cell analysis spinout Deepcell close its second funding round.

Dec 9, 2020

Gohenry waves through $40m

Citi Ventures participated in the first non-crowdfunded equity round to be disclosed by the kids' finance management app developer.

Dec 9, 2020

Ro reels in Workpath

Heritage Group has exited Workpath, a developer of in-home care management software, through an acquisition by Ro.

Dec 9, 2020

Vigil emerges with $50m

Amgen is a shareholder of Vigil Neuroscience, which is developing microglia-based treatments for neurodegenerative diseases.

Dec 9, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here